Assignee

NOVARX

US2 patents

Top patents by PatentIndex Score

US7101543B2Sep 5, 2006

Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells

NOVARX18 citations89

US7740837B2Jun 22, 2010

Genetically modified cells expressing a TGF beta inhibitor, the cells being lung cancer cells

NOVARX8 citations80